T38.892 Poisoning by other hormones and synthetic substitutes, intentional self-harm

Name of the Condition

• Poisoning by other hormones and synthetic substitutes, intentional self-harm

Summary

This condition represents intentional self-harm resulting from exposure to hormones or their synthetic substitutes not classified elsewhere. It includes toxic reactions or adverse effects due to deliberate ingestion, administration, or contact with these substances, requiring immediate medical evaluation.

Causes

The causes involve deliberate exposure to hormones or synthetic substitutes, which may result from intentional ingestion, self-administration, or other self-harm behaviors. Adverse effects can arise from the pharmacological properties of these agents, while intentional exposure may stem from underlying psychological or psychiatric factors.

Risk Factors

• History of intentional self-harm or suicidal behavior
• Access to hormonal medications or substitutes
• Underlying mental health conditions (e.g., depression, anxiety)
• Substance use disorders involving hormonal agents
• Social or environmental stressors contributing to self-harm

Symptoms

Symptoms vary based on the specific hormone or agent involved and may include metabolic disturbances, endocrine imbalances, or organ-specific effects. Adverse reactions could manifest as hyper- or hypofunction of target systems, while poisoning may lead to acute toxicity, depending on the substance and dose.

Diagnosis

Diagnosis requires a thorough patient history, including details of the self-harm event, substance involved, and timing. Clinical evaluation should assess for signs of toxicity, organ dysfunction, or psychiatric distress. Laboratory tests may be used to identify the specific hormone or substitute and measure its concentration.

Treatment Options

Treatment focuses on stabilizing the patient, managing acute toxicity, and addressing underlying psychiatric needs. This may include decontamination, supportive care, antidotes (if available), and psychiatric intervention. Long-term management often involves mental health support and safety planning.

Prognosis and Follow-Up

Prognosis depends on the substance, dose, and timeliness of treatment. Early intervention improves outcomes, but complications may arise from organ damage or delayed psychiatric care. Follow-up includes monitoring for physical recovery and ongoing mental health support to prevent recurrence.

Complications

Complications can include organ failure (e.g., renal, hepatic), metabolic crises, or permanent endocrine dysfunction. Psychological complications, such as persistent suicidal ideation or mood disorders, may also occur.

Lifestyle & Prevention

Prevention involves securing hormonal medications, reducing access to harmful substances, and addressing underlying mental health conditions. Education on safe medication storage and recognizing self-harm risks may help mitigate incidents.

When to Seek Professional Help

Seek immediate medical attention if self-harm with hormonal substances is suspected or confirmed. Prompt evaluation is critical to manage toxicity and address psychiatric needs. Contact emergency services or a healthcare provider immediately.

Tips for Medical Coders

Document the specific hormone or synthetic substitute involved, if known, and confirm the intentional self-harm context. Ensure the code aligns with clinical documentation of the event, including details of exposure and intent. Use this code when the substance is not classified elsewhere and the event is intentional self-harm.